146 related articles for article (PubMed ID: 38634344)
1. Neutrophil antigen antibodies affect engraftment and secondary graft failure in hematopoietic progenitor cell transplantation.
Alswied A; Hassan S; Rai H; Flegel WA
Transfusion; 2024 Jun; 64(6):1050-1058. PubMed ID: 38634344
[TBL] [Abstract][Full Text] [Related]
2. Factors predicting haematopoietic recovery in patients undergoing autologous transplantation: 11-year experience from a single centre.
Bai L; Xia W; Wong K; Reid C; Ward C; Greenwood M
Ann Hematol; 2014 Oct; 93(10):1655-64. PubMed ID: 24870941
[TBL] [Abstract][Full Text] [Related]
3. Donor-Specific HLA Antibodies Are Associated with Graft Failure and Delayed Hematologic Recovery after Unrelated Donor Hematopoietic Cell Transplantation.
Lima ACM; Getz J; do Amaral GB; Loth G; Funke VAM; Nabhan SK; Petterle RR; de Marco R; Gerbase-DeLima M; Pereira NF; Bonfim C; Pasquini R
Transplant Cell Ther; 2023 Aug; 29(8):493.e1-493.e10. PubMed ID: 37220839
[TBL] [Abstract][Full Text] [Related]
4. Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1-2 safety and feasibility study.
Cohen S; Roy J; Lachance S; Delisle JS; Marinier A; Busque L; Roy DC; Barabé F; Ahmad I; Bambace N; Bernard L; Kiss T; Bouchard P; Caudrelier P; Landais S; Larochelle F; Chagraoui J; Lehnertz B; Corneau S; Tomellini E; van Kampen JJA; Cornelissen JJ; Dumont-Lagacé M; Tanguay M; Li Q; Lemieux S; Zandstra PW; Sauvageau G
Lancet Haematol; 2020 Feb; 7(2):e134-e145. PubMed ID: 31704264
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cells versus mesenchymal stem cells combined with cord blood for engraftment failure after autologous hematopoietic stem cell transplantation: a pilot prospective, open-label, randomized trial.
Xiong YY; Fan Q; Huang F; Zhang Y; Wang Y; Chen XY; Fan ZP; Zhou HS; Xiao Y; Xu XJ; Dai M; Xu N; Sun J; Xiang P; Huang XJ; Liu QF
Biol Blood Marrow Transplant; 2014 Feb; 20(2):236-42. PubMed ID: 24216182
[TBL] [Abstract][Full Text] [Related]
6. The Role of HLA Antibodies in HLA Mismatched Allogeneic Hematopoietic Stem Cell Transplantation.
Zhang X; Wang J; Zhou Z; Zhang Y; Liu H; Tong C; Yu C; Lu Y; Zhao Y; Xiong M; Zhou JR; Juan S; Liu DY; Wei Z; Zhang J; Wu T; Lu DP
Clin Transpl; 2014; ():245-50. PubMed ID: 26281152
[TBL] [Abstract][Full Text] [Related]
7. Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype.
Hsieh MM; Fitzhugh CD; Weitzel RP; Link ME; Coles WA; Zhao X; Rodgers GP; Powell JD; Tisdale JF
JAMA; 2014 Jul; 312(1):48-56. PubMed ID: 25058217
[TBL] [Abstract][Full Text] [Related]
8. Complement-Binding Donor-Specific Anti-HLA Antibodies and Risk of Primary Graft Failure in Hematopoietic Stem Cell Transplantation.
Ciurea SO; Thall PF; Milton DR; Barnes TH; Kongtim P; Carmazzi Y; López AA; Yap DY; Popat U; Rondon G; Lichtiger B; Aung F; Afshar-Kharghan V; Ma Q; Fernández-Viña M; Champlin RE; Cao K
Biol Blood Marrow Transplant; 2015 Aug; 21(8):1392-8. PubMed ID: 25985919
[TBL] [Abstract][Full Text] [Related]
9. Outcomes with allogeneic stem cell transplant using cryopreserved versus fresh hematopoietic progenitor cell products.
Wan BA; Lindo L; Mourad YA; Chung S; Forrest D; Kuchenbauer F; Nantel S; Narayanan S; Nevill T; Power M; Rodrigo J; Sanford D; Song K; Stubbins RJ; Sutherland H; Toze CL; White J; Roy C; Hay KA
Cytotherapy; 2024 May; ():. PubMed ID: 38819367
[TBL] [Abstract][Full Text] [Related]
10. Positive Cytotoxic Crossmatch Predicts Delayed Neutrophil Engraftment in Allogeneic Hematopoietic Cell Transplantation from HLA-Mismatched Related Donors.
Kameda K; Nakasone H; Komiya Y; Kanda J; Gomyo A; Hayakawa J; Akahoshi Y; Tamaki M; Harada N; Kusuda M; Ugai T; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Tanihara A; Wada H; Terasako-Saito K; Kikuchi M; Kimura SI; Kako S; Kanda Y
Biol Blood Marrow Transplant; 2017 Nov; 23(11):1895-1902. PubMed ID: 28684373
[TBL] [Abstract][Full Text] [Related]
11. [The impact of donor-to-recipient gender compatibility on outcomes of haploid hematopoietic stem cell transplantation in patients with hematological malignancies].
Hu SS; Wu YB; Zhu PP; Shi JM; Yu J; Zhao YM; Lai XY; Liu LZ; Fu HR; Huang H; Luo Y
Zhonghua Xue Ye Xue Za Zhi; 2022 Dec; 43(12):992-1002. PubMed ID: 36709104
[No Abstract] [Full Text] [Related]
12. Monthly prospective analysis of hematopoietic chimerism after allogeneic hematopoietic cell transplantation.
Lee KH; Lee JH; Choi SJ; Lee JH; Kim S; Seol M; Lee YS; Kim WK; Kwon MR; Choi SJ; Park CJ; Chi HS; Lee JS
Bone Marrow Transplant; 2003 Aug; 32(4):423-31. PubMed ID: 12900780
[TBL] [Abstract][Full Text] [Related]
13. CD34+ hematopoietic progenitor cell dose as a predictor of engraftment and survival in multiple myeloma patients undergoing autologous stem cell transplantation.
Aladağ Karakulak E; Demiroğlu H; Büyükaşik Y; Turgut M; Aksu S; Sayinalp N; Haznedaroğlu IC; Özcebe OI; Göker H
Turk J Med Sci; 2020 Dec; 50(8):1851-1856. PubMed ID: 32512672
[TBL] [Abstract][Full Text] [Related]
14. Impact of hematopoietic chimerism at day +14 on engraftment after unrelated donor umbilical cord blood transplantation for hematologic malignancies.
Moscardó F; Sanz J; Senent L; Cantero S; de la Rubia J; Montesinos P; Planelles D; Lorenzo I; Cervera J; Palau J; Sanz MA; Sanz GF
Haematologica; 2009 Jun; 94(6):827-32. PubMed ID: 19483157
[TBL] [Abstract][Full Text] [Related]
15. Graft Failure Incidence, Risk Factors, and Outcomes in Patients Undergoing Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide.
Mata JR; Zahurak M; Rosen N; DeZern AE; Jones RJ; Ambinder AJ
Transplant Cell Ther; 2024 Jun; 30(6):588-596. PubMed ID: 38521411
[TBL] [Abstract][Full Text] [Related]
16. Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery.
Green MM; Chao N; Chhabra S; Corbet K; Gasparetto C; Horwitz A; Li Z; Venkata JK; Long G; Mims A; Rizzieri D; Sarantopoulos S; Stuart R; Sung AD; Sullivan KM; Costa L; Horwitz M; Kang Y
J Hematol Oncol; 2016 Aug; 9(1):71. PubMed ID: 27535663
[TBL] [Abstract][Full Text] [Related]
17. Importance of day 21 BM chimerism in sustained neutrophil engraftment following double-unit cord blood transplantation.
Avery S; Voss MH; Gonzales AM; Lubin M; Castro-Malaspina H; Giralt S; Kernan NA; Scaradavou A; Hedvat CV; Stevens CE; Barker JN
Bone Marrow Transplant; 2012 Aug; 47(8):1056-60. PubMed ID: 22139066
[TBL] [Abstract][Full Text] [Related]
18. Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy.
Kharfan-Dabaja MA; Kumar A; Ayala E; Aljurf M; Nishihori T; Marsh R; Burroughs LM; Majhail N; Al-Homsi AS; Al-Kadhimi ZS; Bar M; Bertaina A; Boelens JJ; Champlin R; Chaudhury S; DeFilipp Z; Dholaria B; El-Jawahri A; Fanning S; Fraint E; Gergis U; Giralt S; Hamilton BK; Hashmi SK; Horn B; Inamoto Y; Jacobsohn DA; Jain T; Johnston L; Kanate AS; Kansagra A; Kassim A; Kean LS; Kitko CL; Knight-Perry J; Kurtzberg J; Liu H; MacMillan ML; Mahmoudjafari Z; Mielcarek M; Mohty M; Nagler A; Nemecek E; Olson TS; Oran B; Perales MA; Prockop SE; Pulsipher MA; Pusic I; Riches ML; Rodriguez C; Romee R; Rondon G; Saad A; Shah N; Shaw PJ; Shenoy S; Sierra J; Talano J; Verneris MR; Veys P; Wagner JE; Savani BN; Hamadani M; Carpenter PA
Transplant Cell Ther; 2021 Aug; 27(8):642-649. PubMed ID: 34304802
[TBL] [Abstract][Full Text] [Related]
19. Combination treatment of rituximab and donor platelets infusion to reduce donor-specific anti-HLA antibodies for stem cells engraftment in haploidentical transplantation.
Zhang R; He Y; Yang D; Jiang E; Ma Q; Pang A; Zhai W; Wei J; Feng S; Han M
J Clin Lab Anal; 2020 Jul; 34(7):e23261. PubMed ID: 32112480
[TBL] [Abstract][Full Text] [Related]
20. Cryopreservation of Allogeneic Hematopoietic Cell Products During COVID-19 Pandemic: Graft Characterization and Engraftment Outcomes.
Keyzner A; Azzi J; Jakubowski R; Sinitsyn Y; Tindle S; Shpontak S; Kwon D; Isola L; Iancu-Rubin C
Transplant Proc; 2023 Oct; 55(8):1799-1809. PubMed ID: 37210273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
